Lenalidomide with Rituximab for Previously Treated Follicular Lymphoma and Marginal Zone Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Willem J.A. Witlox, Sabine E. Grimm, Rob Riemsma, Nigel Armstrong, Steve Ryder, Steven Duffy, Vanesa Huertas Carrera, Pawel Posadzki, Gillian Worthy, Xavier G.L.V. Pouwels, Bram L.T. Ramaekers, Jos Kleijnen, Manuela A. Joore, Antoinette D.I. van Asselt*

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

5 Citations (Scopus)
80 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Lenalidomide with Rituximab for Previously Treated Follicular Lymphoma and Marginal Zone Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal'. Together they form a unique fingerprint.

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science